OQS Stock Chart & Stats
€1.61
€0.04(2.21%)
At close: 4:00 PM EDT
€1.61
€0.04(2.21%)
Day’s Range― - ―
52-Week Range€1.58 - €2.58
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€528.39M
Enterprise Value€896.46
Total Cash (Recent Filing)€155.22M
Total Debt (Recent Filing)€23.13M
Price to Earnings (P/E)48.9
Beta0.25
Next Earnings
Feb 23, 2027EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding299,167,630
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-4.18
Price to Book (P/B)4.63
Price to Sales (P/S)4.95
P/FCF Ratio57.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€2.28Price Target Upside41.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.02
Revenue Forecast (FY)€136.10M
Bulls Say, Bears Say
Bulls Say
Installed-base And Annuity GrowthThe expanding trophon installed base creates a durable platform for recurring consumables and service revenue. Record placements, upgrades and improving annuity sales strengthen customer retention, increase lifetime account value, and support more predictable cash generation over the next several quarters.
CORIS Product And Regulatory ProgressRegulatory clearances across multiple markets materially improve CORIS commercialization prospects and broaden Nanosonics’ addressable opportunity beyond ultrasound probes. Its stated higher pricing, usage and service economics could provide a meaningful second growth platform as adoption develops.
Conservative Balance Sheet And Capital CapacityA debt-free balance sheet and substantial cash reserve provide flexibility to fund CORIS expansion, product development and operating needs without relying on leverage. The company can also return capital through buybacks while retaining financial resilience for its long-term growth plans.
Bears Say
Revenue And Margin SofteningThe FY2026 revenue decline and multi-year net-margin compression indicate that strong historical growth has recently moderated. Persistent cost, mix or pricing pressure could reduce operating leverage and make future earnings growth more dependent on successful product launches and execution.
Weaker Cash ConversionPositive cash generation remains an asset, but the sharp FY2026 decline and weaker operating-cash coverage show less reliable conversion of reported earnings into liquidity. If this persists, internally funded investment and shareholder returns could compete more directly with operating needs.
CORIS Launch Investment PressureCORIS requires substantial near-term commercial investment before it contributes material revenue, creating a temporary but meaningful earnings burden. Elevated operating costs, alongside modest launch-year sales, may limit margin expansion and reduce profitability leverage over the next several quarters.
Nanosonics Limited News
OQS FAQ
What was Nanosonics Limited’s price range in the past 12 months?
Nanosonics Limited lowest stock price was €1.58 and its highest was €2.58 in the past 12 months.
What is Nanosonics Limited’s market cap?
Nanosonics Limited’s market cap is €528.39M.
When is Nanosonics Limited’s upcoming earnings report date?
Nanosonics Limited’s upcoming earnings report date is Feb 23, 2027 which is in 143 days.
How were Nanosonics Limited’s earnings last quarter?
Nanosonics Limited released its earnings results on Aug 24, 2026. The company reported €0.018 earnings per share for the quarter, beating the consensus estimate of €0.015 by €0.002.
Is Nanosonics Limited overvalued?
According to Wall Street analysts Nanosonics Limited’s price is currently Undervalued.
Does Nanosonics Limited pay dividends?
Nanosonics Limited does not currently pay dividends.
What is Nanosonics Limited’s EPS estimate?
Nanosonics Limited’s EPS estimate is 0.01.
How many shares outstanding does Nanosonics Limited have?
Nanosonics Limited has 299,167,630 shares outstanding.
What happened to Nanosonics Limited’s price movement after its last earnings report?
Nanosonics Limited reported an EPS of €0.018 in its last earnings report, beating expectations of €0.015. Following the earnings report the stock price went down -18.182%.
Which hedge fund is a major shareholder of Nanosonics Limited?
Currently, no hedge funds are holding shares in DE:OQS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nanosonics Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€2.28 (41.49% Upside)
€2.28 (41.49% Upside)
Blogger Sentiment
Bullish
DE:OQS Sentiment 100%
Sector Average 65%
Sector Average 65%
Insider Transactions
Bought Shares
Worth €82.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.18%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
18.98%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nanosonics Limited
Nanosonics Limited, along with its subsidiaries, functions as a global infection prevention enterprise with operations in Australia and beyond. The company focuses on the production and distribution of its trophon ultrasound probe disinfection system, including all related supplies and accessories. Additionally, it dedicates resources to the exploration, development, and market launch of innovative infection control, decontamination products, and their associated technologies. Key offerings from Nanosonics include trophon2, an advanced device for high-level disinfection of ultrasound probes; trophon EPR, a low-temperature, high-level disinfection method specifically for intra-cavity ultrasound probes; and Nanosonics AuditPro, a comprehensive solution for managing compliance with infection control workflows. Established in 2000, Nanosonics Limited is headquartered in Macquarie Park, Australia.
OQS Company Deck
OQS Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive operational and financial picture: constant-currency revenue and EBIT growth, strong trophon profitability and cash generation, record placements and upgrades, product innovation (trophon3/trophon2 Plus), solid annuity and service growth, a debt-free balance sheet with substantial cash and an active buyback. Management also delivered substantial regulatory and commercial progress for CORIS and set explicit FY'27 guidance that anticipates continued growth. Negative items are present but largely manageable and/or transitional: a Q3 consumables dip due to weather, margin moderation from product mix and currency, APAC softness tied to rental models, and elevated near-term OpEx to fund CORIS commercialization which will weigh on near-term profitability. Overall, highlights substantially outweigh the lowlights, with CORIS viewed as a meaningful long-term growth opportunity while trophon continues as a strong cash engine.View all DE:OQS earnings summariesOQS Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€2.28
▲(41.49% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ansell
―
Polynovo
―
Paragon Care Limited
―
Trajan Group Holdings Ltd
―
CleanSpace Holdings Ltd.
―










